HER2 amplification and IGF-IR coexpression in CETCs to explain the resistance to trastuzumab in HER2-positive breast cancers.
Dorothea Zimon
No relevant relationships to disclose
Monika Pizon
No relevant relationships to disclose
Ulrich A. Pachmann
No relevant relationships to disclose
Katharina Pachmann
No relevant relationships to disclose